These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 16934905

  • 1. Role of angiotensin II type-1 and type-2 receptors on vascular smooth muscle cell growth and glucose metabolism in diabetic rats.
    Igarashi M, Hirata A, Nozaki H, Kadomoto-Antsuki Y, Tominaga M.
    Diabetes Res Clin Pract; 2007 Mar; 75(3):267-77. PubMed ID: 16934905
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
    Calò LA, Schiavo S, Davis PA, Pagnin E, Mormino P, D'Angelo A, Pessina AC.
    J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
    [Abstract] [Full Text] [Related]

  • 3. Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan.
    Iwai M, Li HS, Chen R, Shiuchi T, Wu L, Min LJ, Li JM, Tsuda M, Suzuki J, Tomono Y, Tomochika H, Mogi M, Horiuchi M.
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1081-7. PubMed ID: 16990512
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F, Savoia C, De Paolis P, Francia P, Russo A, Maffei A, Venturelli V, Schiavoni M, Lembo G, Volpe M.
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [Abstract] [Full Text] [Related]

  • 5. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N, Izumi-Nagai K, Oike Y, Koto T, Satofuka S, Ozawa Y, Yamashiro K, Inoue M, Tsubota K, Umezawa K, Ishida S.
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
    Sendra J, Llorente-Cortés V, Costales P, Huesca-Gómez C, Badimon L.
    Cardiovasc Res; 2008 Jun 01; 78(3):581-9. PubMed ID: 18281370
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Effects of angiotensin II type 1 receptor blocker on triglyceride metabolism in the liver: experiment with Zucker fatty rats].
    Ran JM, Lao GC, Xu G, Xie B, Zhang Y, Liu W, Feng Q, Guo J.
    Zhonghua Yi Xue Za Zhi; 2008 Jun 10; 88(22):1557-61. PubMed ID: 18956640
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
    Iwai M, Chen R, Li Z, Shiuchi T, Suzuki J, Ide A, Tsuda M, Okumura M, Min LJ, Mogi M, Horiuchi M.
    Circulation; 2005 Sep 13; 112(11):1636-43. PubMed ID: 16145000
    [Abstract] [Full Text] [Related]

  • 12. Olmesartan ameliorates peripheral nerve dysfunction in Zucker diabetic fatty rats.
    Sugimoto K, Kojima K, Baba M, Yasujima M.
    J Hypertens; 2011 Jul 13; 29(7):1337-46. PubMed ID: 21602711
    [Abstract] [Full Text] [Related]

  • 13. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects.
    Kurita S, Takamura T, Ota T, Matsuzawa-Nagata N, Kita Y, Uno M, Nabemoto S, Ishikura K, Misu H, Ando H, Zen Y, Nakanuma Y, Kaneko S.
    Eur J Pharmacol; 2008 Jul 07; 588(2-3):316-24. PubMed ID: 18501344
    [Abstract] [Full Text] [Related]

  • 14. Functional interaction of AT1 and AT2 receptors in fructose-induced insulin resistance and hypertension in rats.
    Hsieh PS, Tai YH, Loh CH, Shih KC, Cheng WT, Chu CH.
    Metabolism; 2005 Feb 07; 54(2):157-64. PubMed ID: 15690308
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of azelnidipine on angiotensin II-mediated growth-promoting signaling in vascular smooth muscle cells.
    Li JM, Iwai M, Cui TX, Min LJ, Tsuda M, Iwanami J, Suzuki J, Mogi M, Horiuchi M.
    Mol Pharmacol; 2005 May 07; 67(5):1666-73. PubMed ID: 15695623
    [Abstract] [Full Text] [Related]

  • 18. Improvement of stunned myocardium in dogs with olmesartan, an angiotensin II type 1 receptor antagonist, is independent of type 2 receptors.
    Kano S, Satoh K, Kaneta S, Ichihara K.
    Pharmacology; 2008 May 07; 82(1):22-9. PubMed ID: 18434761
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin II type 2 receptor-mediated inhibition of norepinephrine release in isolated rat hearts.
    Sasaoka T, Egi Y, Tawa M, Yamamoto A, Ohkita M, Takaoka M, Maruyama T, Akira T, Matsumura Y.
    J Cardiovasc Pharmacol; 2008 Aug 07; 52(2):176-83. PubMed ID: 18670361
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance.
    Ran J, Hirano T, Fukui T, Saito K, Kageyama H, Okada K, Adachi M.
    Metabolism; 2006 Apr 07; 55(4):478-88. PubMed ID: 16546478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.